Omnicell Q2 Revenue Reaches $312M, Full-Year Profit Outlook Raised
OMCL sits 45% above its 52-week low of $28.514 on elevated volume (1.9× avg).
Summary
Omnicell posted Q2 2026 revenue of $312 million and non-GAAP EPS of $0.94, exceeding expectations, and raised full-year profit guidance while trimming revenue and bookings outlooks.
Key Events · Earnings and Guidance · OMCL
-
Q2 Revenue and Earnings Beat
Total revenues reached $312M, up 7% year-over-year. GAAP net income came in at $24M ($0.52/share), compared with $6M a year ago, while non-GAAP net income hit $44M ($0.94/share), up from $21M.
-
Full-Year Profit Guidance Raised
Non-GAAP EBITDA guidance was increased to $175M-$185M, up from a prior implied range of approximately $155M-$165M. Non-GAAP EPS was raised to $2.15-$2.30, compared with the earlier ~$1.90-$2.10.
-
Revenue and Bookings Outlook Trimmed
Full-year revenue guidance was tightened to $1.225B-$1.245B. Product bookings were lowered to $425M-$560M, and annual recurring revenue was reduced to $660M-$680M, reflecting slower growth in certain areas.
-
One-Time Tariff Refund Boost
A $15M IEEPA tariff refund was received, which reduced cost of revenues and boosted Q2 GAAP and non-GAAP profitability and cash flow.
Analysis · OMCL · Technology
A strong second quarter saw revenue land at the high end of expectations while profitability surged — non-GAAP EBITDA nearly doubled year-over-year to $67 million. The company lifted its full-year non-GAAP EBITDA and EPS guidance, underscoring confidence in sustained margin expansion. At the same time, product bookings and annual recurring revenue forecasts were trimmed, suggesting some growth initiatives are taking longer to materialize. A $15 million tariff refund provided a one-time boost, but underlying operational improvements are the real driver. This report confirms the turnaround narrative from Q1 and sets a higher bar for the rest of the year.
At the time of this filing, OMCL was trading at $41.40 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $28.51 to $55.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.